| | | | | | Notes | Mar. 31, 2020 | | Mar. 31, 2019 | | EGP Thousands | | EGP Thousands | | | | | | Net profit for the period | | 2,391,210 | | 2,642,347 | | | | | | Net change in fair value of debt instruments measured at fair value through other comprehensive income | | (4,865,970) | | 2,442,704 | Net change in fair value of debt instruments measured at fair value through other comprehensive income | | (47,321) | | (107,122) | Expected credit loss for fair value of debt instruments measured at fair value through other comprehensive income | | | | | Total other comprehensive income for the year | | (2,522,081) | | 4,977,929 | | | | | | | | | | | Separate cash flow for the period ended March 31, 2020 | | Notes | Mar. 31, 2020 | | Mar. 31, 2019 | | | EGP Thousands | | EGP Thousands | | | | | | Cash flow from operating activities | | | | | Profit before income tax | | 3,648,456 | | 3,757,767 | Adjustments to reconcile net profit to net cash provided by operating activities | | | | | Fixed assets depreciation | 24 | 160,538 | | 131,898 | Impairment charge for credit losses (Loans and advances to customers) | 12 | 1,272,649 | | 634,951 | Other provisions charges | 29 | 439,410 | | 2,077 | Impairment charge for credit losses (due from banks) | 12 | 14,782 | | (7,102) | Impairment charge for credit losses (financial investments) | 12 | (47,321) | | (107,122) | Impairment charge for other assets | 23 | 13,707 | | 24,814 | Exchange revaluation differences for financial assets at fair value through OCI | 21 | 287,889 | | 334,394 | Intangible assets amortization | | - | | 32,552 | Impairment charge financial assets at fair value through OCI | 21 | - | | 45,664 | Exchange differences in financial investments in subsidiary | 22 | 719 | | 1,485 | Utilization of other provisions | 29 | (726) | | 2,461 | Other provisions no longer used | 29 | (38,630) | | (164,335) | Exchange differences of other provisions | 29 | (22,219) | | (37,871) | (Profits) losses from selling property, plant and equipment | 11 | (94) | | - | (Profits) losses from selling financial investments | 21 | (554,113) | | (52,041) | Shares based payments | | 145,069 | | 124,000 | Released (Impairment) charges of investments in associates and subsidiaries | | |
| | 14,100 | | - | Released (Impairment) charges of equity instruments | | 69,863 | | - | Operating profits before changes in operating assets and liabilities | | 5,404,079 | | 4,723,592 | | | | | | Net decrease (increase) in assets and liabilities | | | | | Due from banks | 15 | 211,025 | | (17,549,341) | Treasury bills and other governmental notes | | - | | 15,781,350 | Financial assets at fair value through P&L | 21 | 104,116 | | 2,180,287 | Derivative financial instruments | 20 | 35,892 | | (47,159) | Loans and advances to banks and customers | 18 - 19 | 2,428,551 | | (6,035,057) | Other assets | 40 | 857,769 | | (587,120) | Due to banks | 25 | (1,372,684) | | (3,921,303) | Due to customers | 26 | 5,513,465 | | 8,051,449 | Income tax obligations paid | | (4,639,364) | | (3,762,070) | Other liabilities | 28 | (722,423) | | 3,487,750 | Net cash provided from operating activities | | 7,820,426 | | 2,322,378 | | | | | | Cash flow from investing activities | | | | | Payment for purchases of property, plant, equipment and branches constructions | | (319,089) | | (483,048) | Proceeds from selling property, plant and equipment | 11 | 94 | | - | Proceeds from redemption of financial assets at amortized cost | 21 | 45,639,889 | | 33,452,378 | Payment for purchases of financial assets at amortized cost | 21 | (44,945,839) | | (32,834,360) | Payment for purchases of financial assets at fair value through OCI | 21 | (62,050,349) | | (4,493,603) | Proceeds from selling financial assets at fair value through OCI | | 54,866,521 | | 4,617,766 | Net cash used in investing activities | | (6,808,773) | | 259,133 | | | | | | Cash flow from financing activities | | | Increase (decrease) in long term loans | 27 | (91,576) | (114,541) | Dividend paid | | (3,370,464) | (2,700,544) | Net cash used in (provided from) financing activities | | (3,462,040) | (2,815,085) | | | | | | | Net increase (decrease) in cash and cash equivalent during the year | | (2,450,387) | (233,574) | Beginning balance of cash and cash equivalent | | 22,895,017 | 34,303,645 | Cash and cash equivalent at the end of the year | | 20,444,630 | 34,070,071 | | | | | | | | Cash and cash equivalent comprise: | | | Cash and balances with central bank | 15 | 27,169,495 | 24,741,584 | Due from banks | 16 | 26,640,005 | 51,538,237 | Treasury bills and other governmental notes | 17 | 29,091,960 | 33,831,714 | Obligatory reserve balance with CBE | 15 | (22,186,285) | (17,837,693) | Due from banks with maturities more than three months | | (10,415,104) | (23,971,797) | Treasury bills with maturity more than three months | | (29,855,441) | (34,231,974) | Total cash and cash equivalent | | 20,444,630 | 34,070,071 | | | | | | |
| | | | | | | | | |
Last checked at